40398-0 |
Thyrotropin^1H post dose triple bolus |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Thyrotropin [Units/volume] in Serum or Plasma --1 hour post dose triple bolus |
|
MIN |
DefinitionDescription |
|
|
mIU/L;mcU/mL |
|
|
|
|
|
|
CHAL |
|
40398-0 |
|
|
|
|
Observation |
|
|
|
0 |
TSH 1h p Triple Bolus SerPl-aCnc |
|
|
|
N |
|
1 hour; 1.0Hr; 1h p Triple Bolus; 60 min; 60 minutes; 60M; 60min; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thyroid stimulating hormone; Thyrotropic hormone; Tri; Trip; TSH |
2.7 |
2.15 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
40399-8 |
Thyrotropin^20M post dose triple bolus |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Thyrotropin [Units/volume] in Serum or Plasma --20 minutes post dose triple bolus |
|
MIN |
DefinitionDescription |
|
|
mIU/L;mcU/mL |
|
|
|
|
|
|
CHAL |
|
40399-8 |
|
|
|
|
Observation |
|
|
|
0 |
TSH 20M p Triple Bolus SerPl-aCnc |
|
|
|
N |
|
20M p Triple Bolus; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thyroid stimulating hormone; Thyrotropic hormone; Tri; Trip; TSH |
2.7 |
2.15 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
404-4 |
Pipemidate |
Susc |
Isolate |
Pt |
OrdQn |
MIC |
|
ACTIVE |
Pipemidate [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
404-4 |
|
MIC |
|
|
Observation |
|
|
|
0 |
Pipemidate Islt MIC |
|
|
|
|
|
Acipern; ANTIBIOTIC SUSCEPTIBILITIES; AST; Biopim; Cistomid; Deblaston; Diperpen; Dokol; Faremid; Filtrax; Galusan; ID; Impresial; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Nuril; Pipeacid; Pipedac; Pipedose; Pipefort; Pipemid; Pipemidic acid; Piperamic acid; Pipram; Pipurin; Point in time; Pro-uro; Random; Septidron; Solupemid; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tractur; Urisan; Urodene |
2.19 |
1 |
|
|
|
|
|
|
|
|
|
|
|
0 |
4040-2 |
Sulfonamide |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Sulfonamide [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mg/L;mg/dL |
|
|
|
|
|
|
DRUG/TOX |
|
4040-2 |
|
|
|
|
Both |
|
|
|
0 |
Sulfonamide SerPl-mCnc |
|
|
|
Y |
|
C75; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Sulf; Sulfa; Sulfas; Sulfonamides |
2.73 |
1 |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
40400-4 |
Thyrotropin^30M post dose triple bolus |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Thyrotropin [Units/volume] in Serum or Plasma --30 minutes post dose triple bolus |
|
MIN |
DefinitionDescription |
|
|
mIU/L;mcU/mL |
|
|
|
|
|
|
CHAL |
|
40400-4 |
|
|
|
|
Observation |
|
|
|
0 |
TSH 30M p Triple Bolus SerPl-aCnc |
|
|
|
N |
|
30M p Triple Bolus; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thyroid stimulating hormone; Thyrotropic hormone; Tri; Trip; TSH |
2.7 |
2.15 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
40401-2 |
Thyrotropin^pre dose triple bolus |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Thyrotropin [Units/volume] in Serum or Plasma --pre dose triple bolus |
|
MIN |
DefinitionDescription |
|
|
mIU/L;mcU/mL |
|
|
|
|
|
|
CHAL |
|
40401-2 |
|
|
|
|
Observation |
|
|
|
0 |
TSH pre Triple Bolus SerPl-aCnc |
|
|
|
N |
|
Arbitrary concentration; Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Pl; Plasma; Plsm; Point in time; pre Triple Bolus; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thyroid stimulating hormone; Thyrotropic hormone; Tri; Trip; TSH |
2.7 |
2.15 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
40402-0 |
traZODone |
PrThr |
Gast fld |
Pt |
Ord |
|
|
ACTIVE |
traZODone [Presence] in Gastric fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
40402-0 |
|
|
|
|
Both |
|
|
|
0 |
traZODone Gast Ql |
|
|
|
N |
|
Desyrel; DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Trazon; Trialodine |
2.56 |
2.15 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
40403-8 |
Trimipramine |
PrThr |
Gast fld |
Pt |
Ord |
|
|
ACTIVE |
Trimipramine [Presence] in Gastric fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
40403-8 |
|
|
|
|
Both |
|
|
|
0 |
Trimipramine Gast Ql |
|
|
|
N |
|
Addiction; Cotrimazine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GAST; Gastric contents; Gastric fluid; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Surmontil; TMP |
2.56 |
2.15 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
40404-6 |
Tripelennamine |
PrThr |
Gast fld |
Pt |
Ord |
|
|
ACTIVE |
Tripelennamine [Presence] in Gastric fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
40404-6 |
|
|
|
|
Both |
|
|
|
0 |
Tripelennamine Gast Ql |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Ordinal; Point in time; PR; Pyribenzamine; QL; Qual; Qualitative; Random; Screen |
2.56 |
2.15 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
40405-3 |
Urea |
SRat |
Dial fld |
24H |
Qn |
|
|
ACTIVE |
Urea [Moles/time] in 24 hour Dialysis fluid |
|
MIN |
DefinitionDescription |
|
|
mmol/24 H |
|
|
|
|
|
|
CHEM |
|
40405-3 |
|
|
|
|
Both |
|
|
|
0 |
Urea 24h Dial fld-sRate |
|
|
|
N |
|
1 day; 24 hours; 24HR; Chemistry; Diaf; Dialysate; Dialysis fluid; QNT; Quan; Quant; Quantitative; sRate; Substance rate |
2.7 |
2.15 |
|
|
|
|
|
|
|
mmol/(24.h) |
|
|
|
0 |
40406-1 |
Urea |
SRat |
Body fld |
24H |
Qn |
|
|
ACTIVE |
Urea [Moles/time] in 24 hour Body fluid |
|
MIN |
DefinitionDescription |
|
|
mmol/24 H |
|
|
|
|
|
|
CHEM |
|
40406-1 |
|
|
|
|
Both |
|
|
|
0 |
Urea 24h Fld-sRate |
|
|
|
N |
|
1 day; 24 hours; 24HR; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; QNT; Quan; Quant; Quantitative; sRate; Substance Rate |
2.7 |
2.15 |
|
|
|
|
|
|
|
mmol/(24.h) |
|
|
|
0 |
40407-9 |
Uroporphyrin 1 isomer |
SRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
Uroporphyrin 1 isomer [Moles/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
nmol/24 H |
|
|
|
|
|
|
CHEM |
|
40407-9 |
|
|
|
|
Observation |
|
|
|
0 |
Uropor1 24h Ur-sRate |
|
|
|
N |
|
1 day; 24 hours; 24HR; Chemistry; Hematology; Heme; i; Isom; Octacarboxyl porphyrin; Octacarboxylporphyrin; Octacarboxyphyrin; Porphyria; Porphyria cutanea tarda; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn; Urophorph; Uropor1; Uroporphyrin I |
2.7 |
2.15 |
|
|
|
|
|
|
|
nmol/(24.h) |
|
|
|
0 |
40408-7 |
Uroporphyrin 3 isomer |
SRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
Uroporphyrin 3 isomer [Moles/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
nmol/24 H |
|
|
|
|
|
|
CHEM |
|
40408-7 |
|
|
|
|
Observation |
|
|
|
0 |
Uropor3 24h Ur-sRate |
|
|
|
N |
|
1 day; 24 hours; 24HR; Chemistry; Hematology; Heme; III; Isom; Octacarboxyl porphyrin; Octacarboxylporphyrin; Octacarboxyphyrin; Porphyria; Porphyria cutanea tarda; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn; Urophorph; Uropor3; Uroporphyrin III |
2.7 |
2.15 |
|
|
|
|
|
|
|
nmol/(24.h) |
|
|
|
0 |
40409-5 |
3-Methoxytyramine |
SRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
3-Methoxytyramine [Moles/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/d |
|
|
|
|
|
|
CHEM |
|
40409-5 |
|
|
|
|
Both |
|
|
|
0 |
3Me-tyramine 24h Ur-sRate |
|
|
|
N |
|
1 day; 24 hours; 24HR; 3Me-tyramine; Chemistry; Dopamine metabolite; III; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn |
2.7 |
2.15 |
|
|
|
|
|
|
|
umol/(24.h) |
|
|
|
0 |
4041-0 |
Sulfonamide |
PrThr |
Ser/Bld |
Pt |
Ord |
|
|
ACTIVE |
Sulfonamide [Presence] in Serum or Blood |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
4041-0 |
|
|
|
|
Both |
|
|
|
0 |
Sulfonamide SerBld Ql |
|
|
|
|
|
Blood; C75; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerBld; Serum; Serum or whole blood; SR; Sulf; Sulfa; Sulfas; Sulfonamides; WB; Whole blood |
2.73 |
1 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
40410-3 |
Alkaline phosphatase |
CCnc |
Periton fld |
Pt |
Qn |
|
|
ACTIVE |
Alkaline phosphatase [Enzymatic activity/volume] in Peritoneal fluid |
|
MIN |
DefinitionDescription |
|
|
arb U/L |
|
|
|
|
|
|
CHEM |
|
40410-3 |
|
|
|
|
Both |
|
|
|
0 |
ALP Prt-cCnc |
|
|
|
N |
|
Alk; Alk phos; Alkaline phos; Alkaline phosphatase.total; ALKP; ALP; AP; Ascites; Ascitic fluid; Ascitis; Catalytic Concentration; Chemistry; Hepatology; Liver; MSK; Musculoskeletal; Ortho; Orthopedics; Peritoneal fluid; Phos; Phosphtase; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random |
2.73 |
2.15 |
|
|
|
|
|
|
|
U/L |
|
|
|
0 |
40411-1 |
Amitriptyline |
PrThr |
Gast fld |
Pt |
Ord |
|
|
ACTIVE |
Amitriptyline [Presence] in Gastric fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
40411-1 |
|
|
|
|
Both |
|
|
|
0 |
Amitrip Gast Ql |
|
|
|
N |
|
Amit; Amitrip; Amitriptylene; Amitriptyln; DRUG/TOXICOLOGY; Drugs; Elatrol; Elavil; Endep; GAST; Gastric contents; Gastric fluid; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Trepiline; Tryptanol; Tryptizol |
2.56 |
2.15 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
40412-9 |
Barbiturates |
PrThr |
Meconium |
Pt |
Ord |
|
|
ACTIVE |
Barbiturates [Presence] in Meconium |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
40412-9 |
|
|
|
|
Both |
|
|
|
0 |
Barbiturates Mec Ql |
|
|
|
N |
|
Addiction; Barb; Barbiturate; Barbs; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Mec; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen |
2.73 |
2.15 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
40413-7 |
Barbiturates |
PrThr |
Hair |
Pt |
Ord |
|
|
ACTIVE |
Barbiturates [Presence] in Hair |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
40413-7 |
|
|
|
|
Both |
|
|
|
0 |
Barbiturates Hair Ql |
|
|
|
N |
|
Addiction; Barb; Barbiturate; Barbs; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Har; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen |
2.56 |
2.15 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
40414-5 |
Benzodiazepines |
PrThr |
Meconium |
Pt |
Ord |
|
|
ACTIVE |
Benzodiazepines [Presence] in Meconium |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
40414-5 |
|
|
|
|
Both |
|
|
|
0 |
Benzodiaz Mec Ql |
|
|
|
N |
|
Benz; Benzodiaz; Benzodiazepine; DRUG/TOXICOLOGY; Drugs; Mec; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen |
2.73 |
2.15 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
40415-2 |
Benzodiazepines |
PrThr |
Hair |
Pt |
Ord |
|
|
ACTIVE |
Benzodiazepines [Presence] in Hair |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
40415-2 |
|
|
|
|
Both |
|
|
|
0 |
Benzodiaz Hair Ql |
|
|
|
N |
|
Benz; Benzodiaz; Benzodiazepine; DRUG/TOXICOLOGY; Drugs; Har; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen |
2.56 |
2.15 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
40416-0 |
Caffeine |
PrThr |
Gast fld |
Pt |
Ord |
|
|
ACTIVE |
Caffeine [Presence] in Gastric fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
40416-0 |
|
|
|
|
Both |
|
|
|
0 |
Caffeine Gast Ql |
|
|
|
N |
|
CAFFN; DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen |
2.56 |
2.15 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
40417-8 |
Chromium |
SRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
Chromium [Moles/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
nmol/24 H |
|
|
|
|
|
|
DRUG/TOX |
|
40417-8 |
|
|
|
|
Both |
|
|
|
0 |
Cr 24h Ur-sRate |
|
|
|
N |
|
1 day; 24 hours; 24HR; c609; Chrome; CR; DRUG/TOXICOLOGY; Drugs; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn |
2.75 |
2.15 |
|
|
|
|
|
|
|
nmol/(24.h) |
|
|
|
0 |
40418-6 |
Cotinine |
PrThr |
Meconium |
Pt |
Ord |
|
|
ACTIVE |
Cotinine [Presence] in Meconium |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
40418-6 |
|
|
|
|
Both |
|
|
|
0 |
Cotinine Mec Ql |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Mec; Nicotine metabolite; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen |
2.56 |
2.15 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
40419-4 |
Amphetamine+Methamphetamine |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Amphetamine+Methamphetamine [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
40419-4 |
|
|
|
|
Both |
|
|
|
0 |
Amphet+Methamphet Ur Ql |
|
|
|
N |
|
Addiction; Amph; Amphet; Amphet+Methamphet; Amphetam; Amphetamines; Ampht; Desoxyn; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Methamphet; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Speed; UA; UR; Urn |
2.73 |
2.15 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |